Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oddbjorn Straume

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical & Experimental Metastasis|June 20, 2008
Tumor dormancy due to failure of angiogenesis: role of the microenvironmentGeorge N Naumov, Judah Folkman, Oddbjorn Straume
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
Tumor-vascular interactions and tumor dormancyGeorge N Naumov, Judah Folkman, Oddbjorn Straume, et al.
Expert Opinion on Therapeutic Targets|November 6, 2012
Tumor vasculature: the Achilles' heel of cancer?Tor-Christian Aase Johannessen, Marek Wagner, Oddbjorn Straume, et al.
Journal of the National Cancer Institute|March 2, 2006
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotypeGeorge N Naumov, Elise Bender, David Zurakowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Molecular Cancer Research : MCR|February 28, 2014
Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumorsMichael S Rogers, Katherine Novak, David Zurakowski, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical & Experimental Metastasis|June 20, 2008
Tumor dormancy due to failure of angiogenesis: role of the microenvironmentGeorge N Naumov, Judah Folkman, Oddbjorn Straume
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
Tumor-vascular interactions and tumor dormancyGeorge N Naumov, Judah Folkman, Oddbjorn Straume, et al.
Expert Opinion on Therapeutic Targets|November 6, 2012
Tumor vasculature: the Achilles' heel of cancer?Tor-Christian Aase Johannessen, Marek Wagner, Oddbjorn Straume, et al.
Journal of the National Cancer Institute|March 2, 2006
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotypeGeorge N Naumov, Elise Bender, David Zurakowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistanceGeorge N Naumov, Monique B Nilsson, Tina Cascone, et al.
Molecular Cancer Research : MCR|February 28, 2014
Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumorsMichael S Rogers, Katherine Novak, David Zurakowski, et al.
Pageof 1